The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 3, 1999, Pages 543-547

  Winter, J C ^a   Timineri, Deborah ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Aging; Drug induced stimulus control; EGb 761; Rat

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; GINKGO BILOBA EXTRACT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PIRENPERONE; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATION LEARNING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; TRAINING;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GINKGO BILOBA; INJECTIONS, INTRAPERITONEAL; MALE; PIPERAZINES; PIPERIDINES; PLANT EXTRACTS; PLANTS, MEDICINAL; PYRIDINES; RATS; RATS, INBRED F344; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; REINFORCEMENT SCHEDULE; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0032976884     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00190-7     Document Type: Article

References (29)

1. Balster R.L. Perception of drug effects. Berkeley M.A., Stebbens W.G. Comparative perception, vol. 1. Basic mechanisms. 1990;127-154 Wiley, New York.
2. 1A receptor desensitization. Potective effects of Ginkgo biloba extract [EGb 761] Fundam. Clin. Pharmacol. 9:1995;169-174.
3. 1A receptor antagonist; Prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Eur. J. Pharmacol. 283:1995;133-139.
4. Carney J.M., Christensen H.D. Discriminative stimulus properties of caffeine. Studies using pure and natural products Pharmacol. Biochem. Behav. 13:1980;313.
5. Chermat R., Brochet D., DeFeudis F.V., Drieu K. Interactions of Ginkgo biloba extract [EGb 761], diazepam, and ethyl-beta-carboline-3-carboxylate on social behavior in the rat. Pharmacol. Biochem. Behav. 56:1997;333-339.
6. Colpaert F.C. Drug discrimination. Methods of manipulation, measurement, and analysis Bozarth M.A. Methods of assessing the reinforcing properties of abused drugs. 1990;341-372 Springer, Berlin.
7. DeFeudis F.V. Ginkgo biloba extract [EGb 761]. Pharmacological activities and clinical applications:1991;Elsevier, Paris.
8. 1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology (Berlin). 127:1996;245-254.
9. 1A receptor in working memory. J. Psychopharmacol. 9:1995;242-250.
10. Hofferberth B. The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type, a double-blind, placebo-controlled study on different levels of investigation. Hum. Psychopharmacol. 9:1994;215-222.
11. 1A receptors during aging. Reversal by Ginkgo biloba extract [EGb 761] J. Pharm. Pharmacol. 46:1994;316-318.
12. Kanowski S., Herrmann W.M., Stephan K., Wierich W., Horr R. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry. 29:1996;47-56.
13. Kleijnen, J.; Knipschild, P.: Ginkgo biloba. Lancet 340:1136-1139; 1992.
14. Kleijnen, J.; Knipschild, P.: Ginkgo biloba for cerebral insufficiency. Br. J. Clin. Pharmacol. 34:352-358; 1992.
15. Kloss, P.; Jaggy, H.: Ger. Pat. 2,117,429 to Wilmar Schwabe, C.A. 78, 47787; 1972.
16. 1C receptors. Neurosci. Biobehav. Rev. 16:1992;95-105.
17. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F. A placebo-controlled, double-blind trial of an extract of Ginkgo biloba for dementia. JAMA. 278:1997;1327-1332.
18. Noldner M., Hauer H., Chatterjee S.S. Anseculin hydrochloride. Drugs Future. 1:1996;779-781.
19. Petkov V.D., Kehayov R., Belcheva S., Konstantinova E., Petkov V., Getova D, Markovska V. Memory effects of standardized extracts of Panax ginseng [G115], Ginkgo biloba [GK501] and their combination Gincosan® [PHL-00701]. Planta Med. 59:1993;106-114.
20. Rapin J.R., Lamproglou I., Drieu K., DeFeudis F.V. Demonstration of the "anti-stress" activity of an extract of Ginkgo biloba [EGb 761] using a discrimination learning task. Gen. Pharmacol. 25:1994;1009-1016.
21. Rodriguez De Turco E.B., Droy-Lefaix M.-T., Bazan N.G. EGb 761 inhibits stress-induced polydipsia in rats. Physiol. Behav. 53:1993;1001-1002.
22. Winter E. Effects of an extract of Ginkgo biloba on learning and memory in mice. Pharmacol. Biochem. Behav. 38:1991;109-114.
23. Winter J.C. Drug induced stimulus control. Blackman D., Singer J. Contemporary research in behavioral pharmacology. 1978;341-342 Plenum Press, New York.
24. Winter, J. C.: The stimulus effects of serotonergic hallucinogens in animals. In: Lin, G. C.; Glennon, R. A., eds. NIDA monograph hallucinogens, an update. Washington, D.C.: USGPO; 1994: 157-182.
25. Winter J.C. The effects of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and longevity in the rat. Physiol. Behav. 63:1998;425-433.
26. 1A component Pharmacol. Biochem. Behav. 61:1998;1-5.
27. 1A receptors in memory Pharmacol. Biochem. Behav. 27:1987;625-628.
28. Winter J.C., Rabin R.A. Yohimbine as a serotonergic agent. Evidence from receptor binding and drug discrimination J. Pharmacol. Exp. Ther. 262:1992;682-689.
29. Winter J.C., Rabin R.A. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus. Pharmacol. Biochem. Behav. 30:1988;617-624.